Clinical Trial Update: Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating autologous bone marrow-derived stem cells for decompensated liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Autologous bone marrow-derived stem cells (bone marrow-derived stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED